Cargando…
Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation
BACKGROUND: Previous therapy with anthracyclines (ANT) and conditioning regimen followed by hematopoietic stem cell transplantation (HSCT) represents a high risk for development of cardiotoxicity. The aim of this study was to assess subclinical myocardial damage after HSCT using echocardiography and...
Autores principales: | Roziakova, Lubica, Bojtarova, Eva, Mistrik, Martin, Dubrava, Juraj, Gergel, Jozef, Lenkova, Nadezda, Mladosievicova, Beata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293081/ https://www.ncbi.nlm.nih.gov/pubmed/22321767 http://dx.doi.org/10.1186/1756-9966-31-13 |
Ejemplares similares
-
Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation
por: Chen, Sophia, et al.
Publicado: (2020) -
Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience
por: Chihara, Dai, et al.
Publicado: (2022) -
Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation
por: Lin, Richard J., et al.
Publicado: (2013) -
Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation
por: Du, Wei, et al.
Publicado: (2018) -
Allogeneic hematopoietic stem-cell transplantation for
myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020)